Premier Path Wealth Partners’s AbbVie ABBV Stock Holding History

Premier Path Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.31M	Buy	13,169 +648	+5%	+$139K	0.38%	64
2026 Q1	$2.72M	Buy	12,521 +708	+6%	+$157K	0.35%	62
2025 Q4	$2.7M	Buy	11,813 +482	+4%	+$110K	0.35%	62
2025 Q3	$2.62M	Buy	11,331 +98	+0.9%	+$20K	0.34%	66
2025 Q2	$2.08M	Buy	11,233 +38	+0.3%	+$7.06K	0.29%	79
2025 Q1	$2.35M	Buy	11,195 +769	+7%	+$149K	0.36%	65
2024 Q4	$1.85M	Buy	10,426 +1,353	+15%	+$249K	0.28%	83
2024 Q3	$1.79M	Buy	9,073 +188	+2%	+$35.1K	0.28%	88
2024 Q2	$1.52M	Buy	8,885 +108	+1%	+$17.9K	0.26%	94
2024 Q1	$1.6M	Buy	8,777 +327	+4%	+$56.4K	0.3%	87
2023 Q4	$1.31M	Buy	+8,450	New	+$1.23M	0.29%	87

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Premier Path Wealth Partners's ABBV Position: Q2 2026 in Review

Premier Path Wealth Partners increased its AbbVie (ABBV) stake by 5.2% in Q2 2026, buying an estimated $139K and bringing the position to 13,169 shares worth $3.31M. The position accounts for 0.38% of the portfolio, ranked #64.

Premier Path Wealth Partners first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Premier Path Wealth Partners held 13,169 shares of AbbVie worth $3.31M as of Q2 2026.
Premier Path Wealth Partners bought 648 AbbVie shares in Q2 2026, an estimated $139K.
AbbVie made up 0.38% of Premier Path Wealth Partners's portfolio in Q2 2026, its #64 holding.
Premier Path Wealth Partners first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.